Increase of Natural Killer Activity of Mouse Lymphocytes Following in vitro and in Vivo Treatment with Lithium

References

• Baldassarini R. J. Drugs and the treatment of psychiatric disorders in. Goodman and Gilman's The Pharmacological Basis of Therapeutics7th edition, A. Goodman Gilman, L. S. Goodman, T. W. Rall, F. Murad. Macmillan Publishing Co., New York 1985; 387
   Google Scholar
• Murphy D. L., Goodwin F. K., Bunney W. E., Jr. Leukocytosis during lithium treatment. Amer. J. Psychiat. 1971; 127: 1559
   PubMed Web of Science ®Google Scholar
• O'Connell R. A. Leukocytosis during lithium carbonate treatment. Int. Pharmacopsychiatr. 1970; 4: 30
   Google Scholar
• Greco F. A., Brereton H. D. Lithium and leukocytosis. Ann. Int. Med. 1976; 84: 102
   PubMedGoogle Scholar
• Jacob E., Herbert V. Lithium therapy for neutropenias. J. Clin. Invest. 1974; 53: 35
   Google Scholar
• Gallicchio V. S., Chen M. G. Cell kinetics of lithium-induced granulopoiesis. Cell Tissue Kinet 1982; 15: 179
   PubMedGoogle Scholar
• Gallicchio V. S., Chen M. G. Influence of lithium on proliferation of hematopoietic stem cells. Exp. Hematol. 1981; 9: 804
   PubMedGoogle Scholar
• Levitt L. J., Quesenberry P. J. The effect of lithium on murine hematopoiesis in a liquid culture system. New Engl. J. Med. 1980; 27: 713
   Google Scholar
• Vacek A., Sikulova J., Bertonickova A. Radiation resistance in mice increased following chronic application of Li2 CO3. Acta Radiol. (Oncol.) 1982; 21: 325
   PubMed Web of Science ®Google Scholar
• Gallicchio V. S., Chen M. G., Watts T. D. Specificity of lithium (Li+) to enhance the production of colony stimulating factor (GM-CSF) from mitogen-stimulated lymphocytes in vitro. Cell Immunol. 1984; 85: 58
   PubMedGoogle Scholar
• Cikes M. S., Friberg S., Jr., Klein G. Progressive loss of H-2 antigens with concomitant increase of cell surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J. Natl. Cancer Inst. 1973; 50: 347
   PubMedGoogle Scholar
• Herbeiman R. B., Aoki T., Nunn M. E., Lavrin D. H., Soares N., Gadzar A., Holden H. T., Chang K. S.S. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J. Natl. Cancer Inst. 1974; 53: 1103
   PubMedGoogle Scholar
• Thorn R. M., Herney C. S. Kinetic analysis of target cell destruction by effector T cells. Delineation of parameters related to the frequency of killer cells. J. Immunol. 1976; 117: 2213
   PubMed Web of Science ®Google Scholar
• Henry C., Marbrook J., Vann D. C., Kodlin D., Wofsy C. Limiting Dilution Analysis, in Selected Methods in Cellular Immunology, B. B. Mishell, S. M. Shiigi. Freeman and Co, San FranciscoUSA 1980; 138
   Google Scholar
• Taswell C., MacDonald H. R., Cerottini J. C. Limiting dilution analysis of alloantigen-reactive T lymphocytes. II. Effect of cortisone and cyclophosphamide on cytolytic T lymphocyte precursor frequencies in the thymus. Thymus 1979; 1: 119
   PubMedGoogle Scholar
• Grossman Z., Herberman R. B. Hypothesis on the development of natural killer cells and their relationship to T cells. NK cells and other natural effector cells, R. B. Herberman. Academic Press, New York 1982; 229
   Google Scholar
• Berridge M. J. Inositol triphosphate and diacyl glycerol as second messengers. Biochem. J. 1984; 220: 345
   PubMed Web of Science ®Google Scholar
• Ullberg M., Jondal M., Lanefelt F., Fredholm B. B. Inhibition of human NK cell cytotoxicity by induction of cyclic AMP depends on impaired target cell recognition. Scand. J. Immunol. 1983; 17: 355
   PubMedGoogle Scholar
• Kyohara T., Lauzon R., Haliotis T., Roder J. Target cell structures, recognition sites and the mechanism of NK cytotoxicity. Immunobiology of Natural Killer Cells, E. Lotzova, R. B. Herberman. CRC Press, Inc., Boca Raton, Florida 1986; 107
   Google Scholar
• Djeu J. Y., Heinbaugh J. A., Vieira K. D., Holden H. T., Herberman R. B. The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by Poly I:C. Immunopharmacology 1979; 1: 231
   PubMedGoogle Scholar
• Herberman R. B., Djeu J. Y., Kay H. D., Drtaldo J. R., Riccardi C., Bonnard C. D., Holden H. T., Fagnani R., Santoni A., Puccetti P. Natural killer cells: characteristics and regulation of activity. Immunol. Rev. 1979; 44: 43
   PubMed Web of Science ®Google Scholar
• Mantovani A., Luini W., Peri G., Vecchi A., Spreafico F. Effect of chemotherapeutic agents on natural cell mediated cytotoxicity in mice. J. Natl. Cancer Inst. 1978; 61: 1255
   PubMed Web of Science ®Google Scholar
• Riccardi C., Santoni A., Barlozzari T., Herberman R. B. Role of NK cells in rapid in vivo clearance of radiolabeled tumor cells. Natural Cell-mediated Immunity against Tumors, R. B. Herberman. Academic Press Inc., New York 1980; 1121
   Google Scholar
• Peppoloni S., Mathieson B. J., Herberman R. B., Overton R. W., Gorelik E. In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. Cancer Immunol. Immunother. 1987; 24: 49
   PubMedGoogle Scholar